TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Atlas Antibodies AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
12,471
|
14,390
|
14,072 |
| Financial expenses |
2,389
|
2,206
|
919 |
| Earnings before taxes |
-34,172
|
4,565
|
7,393 |
| EBITDA |
4,634
|
5,292
|
4,668 |
| Total assets |
221,432
|
265,463
|
261,261 |
| Current assets |
27,878
|
27,245
|
22,904 |
| Current liabilities |
920
|
1,387
|
1,876 |
| Equity capital |
175,670
|
217,880
|
213,658 |
| - share capital |
43
|
44
|
44 |
| Employees (average) |
58
|
70
|
82 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
79.3%
|
82.1%
|
81.8% |
| Turnover per employee |
215
|
206
|
172 |
| Profit as a percentage of turnover |
-274.0%
|
31.7%
|
52.5% |
| Return on assets (ROA) |
-14.4%
|
2.6%
|
3.2% |
| Current ratio |
3030.2%
|
1964.3%
|
1220.9% |
| Return on equity (ROE) |
-19.5%
|
2.1%
|
3.5% |
| Change turnover |
-1,430
|
277
|
945 |
| Change turnover % |
-10%
|
2%
|
7% |
| Chg. No. of employees |
-12
|
-12
|
3 |
| Chg. No. of employees % |
-17%
|
-15%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.